SEATTLE (AP) _ Cascadian Therapeutics Inc. (CASC) on Thursday reported a loss of $10.5 million in its fourth quarter.
On a per-share basis, the Seattle-based company said it had a loss of 47 cents.
For the year, the company reported that its loss widened to $57.7 million, or $3.13 per share.
In the final minutes of trading on Thursday, the company's shares hit $4.14. A year ago, they were trading at $6.66.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CASC at https://www.zacks.com/ap/CASC
Keywords: Cascadian Therapeutics, Earnings Report